ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹522 Cr | ₹531 Cr | ₹129 Cr | ₹144 Cr | ₹287 Cr |
What is the latest Net Current Assets ratio of ORCHID PHARMA ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹522 Cr |
| Mar2024 | ₹531 Cr |
| Mar2023 | ₹129 Cr |
| Mar2022 | ₹144 Cr |
| Mar2021 | ₹287 Cr |
How is Net Current Assets of ORCHID PHARMA Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹522 Cr | -1.70 | |
| Mar2024 | ₹531 Cr | 311.08 | |
| Mar2023 | ₹129 Cr | -10.07 | |
| Mar2022 | ₹144 Cr | -49.96 | |
| Mar2021 | ₹287 Cr | - | |
Compare Net Current Assets of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹2,602.4 Cr | -4.7% | -23.2% | -39% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹420,555.0 Cr | -1.5% | 1.6% | 1.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,889.0 Cr | -2% | -4.3% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,073.0 Cr | -0.8% | 0.5% | 32% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,133.0 Cr | -2.7% | -1.6% | 6.9% | Stock Analytics | |
| CIPLA | ₹98,492.9 Cr | -3.9% | -9.1% | -18.4% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -4.7% |
-23.2% |
-39% |
| SENSEX | -2.6% |
-10.2% |
-1.6% |
You may also like the below Video Courses